Sabby Management, LLC Painreform Ltd. Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.26 - $2.83 $148,085 - $332,604	-117,528 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.56 - $4.08 $588,646 - $938,155	-229,940 Reduced 66.18%	117,528 $326,000
Q2 2021 Aug 16, 2021	BUY	$2.33 - $4.7 $40,700 - $82,099	17,468 Added 5.29%	347,468 $980,000
Q1 2021 May 17, 2021	BUY	$4.06 - $6.82 $1.09 Million - $1.83 Million	268,394 Added 435.66%	330,000 $1.46 Million
Q4 2020 Feb 16, 2021	SELL	$4.16 - $5.4 $1.59 Million - $2.07 Million	-383,335 Reduced 86.15%	61,606 $275,000
Q3 2020 Nov 16, 2020	BUY	$4.6 - $6.74 $2.05 Million - $3 Million	444,941 New	444,941 $2.05 Million

Ticker PRFX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,634,200
Market Cap $5.64M
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-oper...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.